PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24567279-1	2014	BACKGROUND: The antiepileptic drug lacosamide has a low potential for drug-drug interactions, but is a substrate and moderate inhibitor of the cytochrome P450 (CYP) enzyme CYP2C19.	Lacosamide	35-45	cytochrome P450 family 2 subfamily C member 19	Homo sapiens	172-179	
22850102-3	2012	The bioavailability of lacosamide is 100% and is unaffected by food intake; protein binding is low; it is metabolized by CYP2C19 into inactive O-desmethyl lacosamide.	Lacosamide	23-33	cytochrome P450 family 2 subfamily C member 19	Homo sapiens	121-128